Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$16.08 -0.04 (-0.25%)
As of: Sep 4, 2026 · 3:59 PM EDT

Aurinia Pharmaceuticals (AUPH) Gross Margin (QoQ) (2020 - 2026)

Analysis

Aurinia Pharmaceuticals (AUPH) Gross Margin (QoQ) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Aurinia Pharmaceuticals 2.10 Bn 1.66 Bn 76.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 49.00
Mar 31, 2026 304.00
Dec 31, 2025 -28.00
Sep 30, 2025 -97.00
Jun 30, 2025 356.00
Mar 31, 2025 -445.00
Dec 31, 2024 -37.00
Sep 30, 2024 667.00
Jun 30, 2024 -17.00
Mar 31, 2024 -345.00
Dec 31, 2023 45.00
Sep 30, 2023 -865.00
Jun 30, 2023 -254.00
Mar 31, 2023 357.00
Dec 31, 2022 -40.00
Sep 30, 2022 129.00
Jun 30, 2022 -449.00
Mar 31, 2022 87.00
Dec 31, 2021 -32.00
Sep 30, 2021 292.00